Tsumura & Co. (TYO:4540)
4,368.00
-32.00 (-0.73%)
Feb 19, 2025, 3:30 PM JST
Tsumura & Co. Revenue
Tsumura & Co. had revenue of 47.70B JPY in the quarter ending December 31, 2024, with 17.71% growth. This brings the company's revenue in the last twelve months to 171.79B, up 15.46% year-over-year. In the fiscal year ending March 31, 2024, Tsumura & Co. had annual revenue of 150.85B with 7.71% growth.
Revenue (ttm)
171.79B
Revenue Growth
+15.46%
P/S Ratio
1.91
Revenue / Employee
41.52M
Employees
4,138
Market Cap
327.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 150.85B | 10.80B | 7.71% |
Mar 31, 2023 | 140.04B | 10.50B | 8.10% |
Mar 31, 2022 | 129.55B | -1.34B | -1.02% |
Mar 31, 2021 | 130.88B | 7.64B | 6.19% |
Mar 31, 2020 | 123.25B | 2.34B | 1.94% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |